Shuzou Tanimoto
Overview
Explore the profile of Shuzou Tanimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asano T, Maeno Y, Nakano M, Taguri M, Miyasaka M, Nakai D, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792317
: Despite the encouragement of early initiation and titration of guideline-directed medical therapy (GDMT) for the treatment of heart failure (HF), most patients do not receive an adequate type and...
2.
Kohashi K, Nakano M, Isshiki T, Maeno Y, Tanimoto S, Asano T, et al.
Int Heart J
. 2023 Jul;
64(4):535-542.
PMID: 37460322
Rapid reperfusion by primary percutaneous coronary intervention (pPCI) is an established strategy for the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Pre-hospital electrocardiogram (PH-ECG) transmission by the emergency...
3.
Naito K, Nakano M, Iwasa A, Maeno Y, Shintani Y, Yamakawa T, et al.
J Arrhythm
. 2020 Aug;
36(4):634-641.
PMID: 32782633
Background: The real-world safety and efficacy of uninterrupted anticoagulation treatment with edoxaban (EDX) or warfarin (WFR) during the peri-procedural period of catheter ablation (CA) for atrial fibrillation (AF) are yet...
4.
Hara H, Tanabe K, Tanimoto S, Aoki J, Yachi S, Kishi S, et al.
J Cardiol Cases
. 2018 Dec;
7(6):e161-e163.
PMID: 30533152
A 46-year-old man with a history of hypertension, chronic kidney disease, and chronic aortic dissection classified as DeBakey type IIIB was referred to our hospital with chest and back pain....
5.
Matsushita K, Harada K, Miyazaki T, Miyamoto T, Kohsaka S, Iida K, et al.
J Hypertens
. 2018 Sep;
37(3):643-649.
PMID: 30234786
Objective: No agents have been proven to improve survival in heart failure with preserved ejection fraction (HFpEF), but the phenotypic diversity of HFpEF suggests it may be possible to identify...
6.
Asami M, Tanabe K, Ito S, Yoshida E, Aoki J, Tanimoto S, et al.
Int Heart J
. 2018 May;
59(3):489-496.
PMID: 29743417
Serum indoxyl sulfate (IS; a uremic toxin) levels, which are significantly higher in patients with chronic kidney disease, including those undergoing hemodialysis, than in the robust, are associated with both...
7.
Horiuchi Y, Tanimoto S, Aoki J, Fuse N, Yahagi K, Koseki K, et al.
Int J Cardiol
. 2018 May;
267:217.
PMID: 29731351
No abstract available.
8.
Horiuchi Y, Tanimoto S, Latif A, Urayama K, Aoki J, Yahagi K, et al.
Int J Cardiol
. 2018 Apr;
262:57-63.
PMID: 29622508
Background: Acute heart failure (AHF) is a heterogeneous disease caused by various cardiovascular (CV) pathophysiology and multiple non-CV comorbidities. We aimed to identify clinically important subgroups to improve our understanding...
9.
Matsushita K, Harada K, Miyazaki T, Miyamoto T, Iida K, Tanimoto S, et al.
Heart Vessels
. 2018 Mar;
33(9):1022-1028.
PMID: 29541844
The relationship between glycemic control and outcome in patients with heart failure (HF) remains contentious. A recent study showed that patients with HF with mid-range ejection fraction (HFmrEF) more frequently...
10.
Horiuchi Y, Tanimoto S, Aoki J, Fuse N, Yahagi K, Koseki K, et al.
Int J Cardiol
. 2018 Mar;
257:143-149.
PMID: 29506686
Background: Mismatch between right- and left-sided filling pressures is poorly understood in heart failure with preserved ejection fraction (HFpEF). Methods And Results: We retrospectively analyzed 170 patients with HFpEF (EF≥40%)...